You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
New York-based law firm Kaplan Fox & Kilsheimer LLP has announced it is investigating potential securities law violations against Alignment Healthcare, Inc. (NASDAQ: ALHC) following a whistleblower complaint alleging accounting irregularities. The complaint, which surfaced on July 8, 2026, alleges the company artificially inflated its reported financial results, including a key non-GAAP metric. Shares of Alignment Healthcare fell $4.02, or 16.7%, to close at $20.03 on the day the news emerged, a move that investors and legal observers may continue to monitor closely.
Key Points
- Alignment Healthcare, Inc. (NASDAQ: ALHC) is the subject of a securities law investigation by Kaplan Fox & Kilsheimer LLP
- A former executive filed a whistleblower complaint alleging systematic misclassification of operating expenses as capital expenditures
- ALHC shares fell $4.02 per share, or 16.7%, to close at $20.03 on July 8, 2026, following the news
- Investors who suffered losses are being contacted as the investigation seeks additional information
Whistleblower Complaint Alleges Inflated Adjusted EBITDA at Alignment Healthcare
According to the announcement, a former Alignment Healthcare executive filed a whistleblower complaint...
Read Full Story:
https://news.google.com/rss/articles/CBMi-AFBVV95cUxNZFdTNzRTWmlkTDV5WUpGQ3NU...